Debreceni Egyetem, Klinikai Központ, Auguszta

Debrecen 4032

0 studies enrolling now · 1 studies all time

What they study most

Antibody-mediated Rejection

Studies at this site

• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early